# Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT

> **NCT01151852** · PHASE3 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 81 (actual)

## Conditions studied

- Gastrointestinal Stromal Tumors

## Interventions

- **DRUG:** Imatinib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01151852
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2020-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01151852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01151852, "Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01151852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*